8-hydroxy-2'-deoxyguanosine and lipid peroxidation in patients with heart failure;Valores de 8-hidroxi-2'-desoxiguanosina y de peroxidación lipídica en pacientes con insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 59, Issue 11, 2006, Pages 1140-1145

  Rivera, Miguel ^a,f   Roselló Lletí, Esther ^a   García de Burgos, Fernando ^b   Bertomeu, Vicente ^c   Payá, Rafael ^d   Cortés, Raquel ^a   Martínez Dolz, Luís ^a   Jordán, Alejandro ^b   Pérez Boscá, Jose L ^d   Salvador, Antonio ^a   Marín, Fancisco ^e   Sogorb, Francisco ^e   Valero, Ricardo ^c   Miró, Vicente ^a   Portolés, Manuel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d Hospitla General   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^f UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Free radicals; Heart failure; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; FREE RADICAL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; QUESTIONNAIRE;

EID: 33846449545     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095783     Document Type: Article

References (40)

1. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002; 106:92-9.
2. Sirera R, Salvador A, Roldán I, Talens R, González-Molina A, Rivera M. Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels. Eur J Heart Fail. 2003;5:27-31.
3. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 2004;109:544-9.
4. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:1352-6.
5. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65:245-8.
6. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005; 115:500-8.
7. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999;85:357-63.
8. Siles E, Martínez-Lara E, Núñez MI, Muñoz-Gámez JA, Martín-Oliva D, Valenzuela MT, et al. PARP-1-dependent 3-nitrotyrosine protein modification after DNA damage. J Cell Biochem. 2005;96:709-15.
9. Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res. 2003;37:1307-17.
10. Kouda K, Nakamura H, Fan W, Horiuchi K, Takeuchi H. The relationship of oxidative DNA damage marker 8-hydroxydeoxyguanosine and glycoxidative damage marker pentosidine. Clin Biochem. 2001;34:247-50.
11. Pérez O, Castro P, Díaz-Araya G, Nettle D, Moraga F, Chiong M, et al. Persistencia del estrés oxidativo postrasplante cardiaco: estudio comparativo entre pacientes con trasplante cardiaco y con insuficiencia cardiaca crónica estable. Rev Esp Cardiol. 2002; 55:831-7.
12. Kadiiska MB, Gladen BC, Baird DD, Germolee D, Graham LB, Parker CE, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCI(4) poisoning? Free Radic Biol Med. 2005;38:698-710.
13. Bergam V, Leanderson P, Starkhammar H, Tagesson C. Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy preceding stem cell transplantation. Free Radic Biol Med. 2004;36:300-6.
14. Sanguini V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M, et al. CD4 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol. 2005;45:35-42.
15. Farbanghoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, et al. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol. 2003;35:1439-48.
16. Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol. 2005;45:589-94.
17. Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A, et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol. 2004;94:301-5.
18. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40.
19. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335:490-8.
20. Schiller NB, Shah PNI, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiograpry Committe on Standards, Subcommitte on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
21. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods. 1993;30:55-67.
22. Gredilla R, Phaneuf S, Selman C, Kendaiah S, Leeuwenburgh C, Barja G. Short-term caloric restriction and sites of oxygen radical generation in kidney and skeletal muscle mitochondria. Ann NY Acad Sci. 2004,1019:333-42.
23. Gackowski D, Kowalewski J, Siomek A, Olinski R. Oxidative DNA damage and antioxidant vitamin level: comparison among lung cancer patients, healthy smokers and nonsmokers. Int J Cancer. 2005; 114:153-6.
24. Park KS, Kim JH, Kim MS, Kim JM, Kim SK, Choi JY, et al. Effects of insulin and antioxidant on plasma 8-hydroxyguanme and tissue 8-hydroxydeoxyguanosine in Streptozotocin-induced diabetic rats. Diabetes. 2001;50:2837-41.
25. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, et al. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 2004; 18:589-91.
26. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002;59:794-8.
27. Akbas H, Ozden M, Kanko M, Maral H, Bulbul S, Yavuz S, et al. Protective antioxidant effects of carvedifol in a rat model of ischemia-reperfusion injury. J Int Med Res. 2005;33:528-36.
28. Stokes KY, Granger DN. Hypercholesterolemia: its impact on ischemia-reperfusion injury. Expert Rev Cardiovasc Ther. 2005;3:1061-70.
29. Zimiani K, Guarnier FA, Miranda HC, Watanabe MA, Cecchini R. Nitric oxide mediated oxidative stress injury in rat skeletal muscle subjected to ischemia/reperfusion as evaluated by chemiluminescence. Nitric Oxide. 2005; 13:196-203.
30. Liu P, Xu B, Cavalieri TA, Hock CE. Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R, Am J Physiol Heart Circ Physiol. 2004;287:H2719-27.
31. Parik T, Allikmets K, Teesalu R, Zilmer M. Oxidative stress and hyperinsulinaemia in essential hypertension: different facets of increased risk. J Hypertens. 1996; 14:407-10.
32. Kinoshita A, Wanibuchi H, Imaoka S, Ogawa M, Masuda C, Morimura K, et al. Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21 (WAF1/Cip1), cyclin D1 and Ogg1 Carcinogenesis. 2002;23:341-9.
33. Schulpis KH, Tsakiris S, Traeger-Synodmos J, Papassotiriou I. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem. 2005;38:239-42.
34. Godfraind T. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Philos Trans R Soc Lond B Biol Sci. 2005;360:2259-72.
35. Miranda KM, Nagasawa HT, Toscano JP. Donors of HNO. Curr Top Med Chem. 2005;5:649-64.
36. Dzhanashiya PKh, Vladytskaya OV, Salibegasshvili NV. Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis. Bull Exp Biol Med. 2004;138:412-4.
37. Greenberg B. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial. Rev Cardiovasc Med. 2004;5 Suppl 1: 10-7.
38. Erbs S, Gielen S, Linke A, Mobius-Winkler S, Adams V, Baither Y, et al. Improvement of peripheral endothelial dysfunction by acute vitamine C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J. 2003; 146:280-5.
39. Tousoulis D, Antoniades C, Vassiliadou C, Toutouza M, Pitsavos C, Tentolouris C, et al. Effects of combined administration of low dose atorvastatin and vitamine E on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Fail. 2005;7:1126-32.
40. Eicken A, Fratz S, Gutfried C, Balling G, Schwaiger M, Lange R, et al. Hearts late after fontan operation have normal mass, normal volume, and reduced systolic function: a magnetic resonance imaging study. J Am Coll Cardiol. 2003;42:1061-5.